Sign in
4

Changes in Ownership

Xenon Pharmaceuticals Inc. Filed Acc 0001209191-21-064931

Director sold 17,557 shares at $31.33 ($550,061)

From the SEC's structured data for this filing

Trades in this filing

PIMSTONE SIMON N. · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-11-15 Sale : show line 1 in the form −17,557 $31.33 $550,061 210,186 D
Open-market sales · 17,557 sh · avg $31.33 · $550,061
Loading xslF345X03/doc4.xml…